Dofequidar, CAS [[129716-58-1]]

Produktübersicht

• Artikelname: Dofequidar, CAS [[129716-58-1]]
• Artikelnummer: MCE-HY-17013
• Hersteller Artikelnummer: HY-17013
• Alternativnummer: MCE-HY-17013-5MG,MCE-HY-17013-10MMX1ML,MCE-HY-17013-25MG,MCE-HY-17013-10MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien
• Alternative Synonym: MS-209 (free base)

Produktbeschreibung

Dofequidar (MS-209 free base) is an orally active quinoline compoundthat blocks P-glycoprotein (P-gp) and multidrug resistance-associated protein-1 (MDR-1). Dofequidar has highly potent reversing effect on multidrug-resistant tumor cells. Dofequidar competitively inhibits ABCB1/P-gp, ABCC1/MRP-1, blocks the efflux of chemotherapeutic agents, increases the drug concentration in cancer cells, and enhances the chemotherapeutic effect[1][2].

Produkteigenschaften

• Molekulargewicht: 481.59
• Reinheit: 98.17
• CAS Nummer: [129716-58-1]
• Formel: C30H31N3O3
• Target-Kategorie: P-glycoprotein

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound